Clinical Trials Logo

Clinical Trial Summary

The NUCaCD study aims to develop a reliable registry of patients suffering inflammatory bowel diseases in the Republic of Kazakhstan.


Clinical Trial Description

The NUCaCD aims to study the prevalence of inflammatory bowel diseases in the Republic of Kazakhstan and create a reliable database, which will greatly facilitate future planning of the volume of health resources needed to address these diseases management and will help to optimize preventive measures and will support future research to better understand the etiology, new options treatment and factors affecting prognosis, relapses, development of complications and quality of life. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05189327
Study type Observational [Patient Registry]
Source Kazakhstan Scientific Society for Study of intestine diseases
Contact Jamilya Kaibullayeva, PhD
Phone +77471051195
Email [email protected]
Status Recruiting
Phase
Start date December 10, 2021
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04844606 - A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) Phase 3
Recruiting NCT04148274 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis
Recruiting NCT04695964 - Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis N/A